DUSP12P1

Across TCGA pan-cancer cohorts, DUSP12P1 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated DUSP12P1 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher DUSP12P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated DUSP12P1 expression acts as an unfavorable survival marker, although some lineages such as UCS show a favorable association.

READ, KIRC, and PAAD are the cancer types where DUSP12P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Tertile	All	0.182	0.798	.010	45	view →
KIRC	OS	Tertile	All	0.444	0.654	.003	18	view →
PAAD	OS	Tertile	II,III,IV	0.213	0.556	.014	18	view →
UCS	OS	Tertile	All	0.917	0.501	.012	18	view →
MESO	OS	Tertile	III,IV	0.258	0.583	.037	9	view →
UCEC	DFS	Tertile	All	0.548	0.662	.038	6	view →
KIRP	OS	Tertile	All	0.268	0.724	.017	3	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

DUSP12P1–READ (DFS)

Open the READ breakdown →